KURA
Kura Oncology, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website kuraoncology.com
- Employees(FY) 131
- ISIN US50127T1097
Performance
+6.74%
1W
+19.26%
1M
+7.52%
3M
+143.89%
6M
+54.17%
YTD
+78.5%
1Y
Profile
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Investment Analysis Report: KURA
Overview
In this investment analysis report, we will delve into a comprehensive evaluation of KURA, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash fl...
Technical Analysis of KURA 2024-05-10
Overview:
In analyzing the technical indicators for KURA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-05-14 11:44
- 2024-05-14 07:30
- 2024-05-13 19:30
- 2024-05-08 07:30
- 2024-05-07 20:30
2 Incredible Growth Stocks to Buy Hand Over Fist(Yahoo Finance)
- 2024-05-07 19:30
- 2024-05-06 10:14
- 2024-05-03 07:30
- 2024-05-03 04:03
- 2024-05-02 19:30
- 2024-05-02 16:48
Kura Oncology: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-02 16:05
Kura Oncology Reports First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-05-02 08:58
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024(Investorplace)
- 2024-05-02 04:05
Kura Oncology Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-25 07:30
Kura Oncology to Report First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-04-24 19:30
Kura Oncology to Report First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-22 07:30
- 2024-04-21 19:30
- 2024-04-10 07:30
- 2024-04-09 19:30
- 2024-04-05 07:30
- 2024-04-04 19:30
- 2024-03-06 07:30
- 2024-03-05 18:30
- 2024-03-01 17:00
- 2024-03-01 04:00
- 2024-02-28 09:56
- 2024-02-28 06:56
Q4 2023 Kura Oncology Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-27 16:44
- 2024-02-27 16:10
Kura Oncology: Q4 Earnings Snapshot(Associated Press Finance)
Page 1 of 6
previousnext